42
Growth Score
pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1211572
AnaMar AB is a Swedish-based drug discovery company
Ulf Ljungberg: CEO and member of the Board of Directors- Göran Tornling: CMO
About the Company
AnaMar AB, a Swedish-based drug discovery company, is developing orally bioavailable, peripherally acting 5-HT2B receptor antagonists designed to prevent pathological fibrotic processes. The company is operative in discovery and the early phases of drug development, from the idea stage to clinical trials. This includes invention and optimization of
new drug candidates, evaluation of preclinical efficacy and safety and finally, confirmatory early clinical studies in patients with fibrotic disease.
